Effect of neuromuscular blockade reversal on early postoperative pulmonary function after thoracoscopic lung resection: a multicenter, double-blind, randomized controlled trial protocol

Pulmonary function decreases immediately after thoracic surgery, a change that is often overlooked and lacks effective intervention strategies. Residual neuromuscular blockade (RNMB) is an important, controllable factor. This study aims to compare the effects of sugammadex versus neostigmine for neuromuscular blockade reversal on pulmonary function recovery at 1 h postoperatively. This multicenter, double-blind RCT will enroll 240 patients scheduled for unilateral thoracoscopic partial lung resection (≤ 1 segment). Eligible participants will be randomly assigned in a 1:1 ratio to the sugammadex group (2 mg/kg) or the neostigmine group (0.03 mg/kg co-administered with atropine 0.015 mg/kg). The primary outcome is the percentage decrease in forced expiratory volume in one second (FEV1) at 1 h postoperatively relative to the preoperative baseline. Secondary outcomes include the percentage decrease in FEV1 from baseline on postoperative days 1 to 3, and pain scores measured by the verbal response scale (VRS) at multiple postoperative time points. Other outcomes include opioid consumption, recovery time of gastrointestinal function, incidence of postoperative nausea and vomiting (PONV), 15-item Quality of Recovery (QoR-15) scores, and the incidence of postoperative pulmonary complications (PPCs). This study aims to assess the superiority of sugammadex over neostigmine reversal regimens in improving 1-hour postoperative pulmonary function following thoracoscopic lung resection. The findings will provide mechanistic evidence on whether optimized neuromuscular reversal improves early postoperative pulmonary function, and may inform the design of future confirmatory trials with patient-centered outcomes. ClinicalTrials.gov, NCT07309393.

Authors

Publication Details

Journal
Figshare
Published
2026-11-16
DOI
https://doi.org/10.6084/m9.figshare.35023599
Primary Topic
Anesthesia and Sedative Agents
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effect of neuromuscular blockade reversal on early postoperative pulmonary function after thoracoscopic lung resection: a multicenter, double-blind, randomized controlled trial protocol

Jingwen Zhuang, Jinchao Song, Shiyou Wei, Yadan Liu et al.
Figshare
Anesthesia and Sedative Agents
article

Effect of neuromuscular blockade reversal on early postoperative pulmonary function after thoracoscopic lung resection: a multicenter, double-blind, randomized controlled trial protocol

Jingwen Zhuang, Jinchao Song, Shiyou Wei, Yadan Liu, Jianmang Yu, Pingping Xin, Junyi Huang, Xin Lv, Chao Liu, Lihua Wang
article en

Abstract

Pulmonary function decreases immediately after thoracic surgery, a change that is often overlooked and lacks effective intervention strategies. Residual neuromuscular blockade (RNMB) is an important, controllable factor. This study aims to compare the effects of sugammadex versus neostigmine for neuromuscular blockade reversal on pulmonary function recovery at 1 h postoperatively. This multicenter, double-blind RCT will enroll 240 patients scheduled for unilateral thoracoscopic partial lung resection (≤ 1 segment). Eligible participants will be randomly assigned in a 1:1 ratio to the sugammadex group (2 mg/kg) or the neostigmine group (0.03 mg/kg co-administered with atropine 0.015 mg/kg). The primary outcome is the percentage decrease in forced expiratory volume in one second (FEV1) at 1 h postoperatively relative to the preoperative baseline. Secondary outcomes include the percentage decrease in FEV1 from baseline on postoperative days 1 to 3, and pain scores measured by the verbal response scale (VRS) at multiple postoperative time points. Other outcomes include opioid consumption, recovery time of gastrointestinal function, incidence of postoperative nausea and vomiting (PONV), 15-item Quality of Recovery (QoR-15) scores, and the incidence of postoperative pulmonary complications (PPCs). This study aims to assess the superiority of sugammadex over neostigmine reversal regimens in improving 1-hour postoperative pulmonary function following thoracoscopic lung resection. The findings will provide mechanistic evidence on whether optimized neuromuscular reversal improves early postoperative pulmonary function, and may inform the design of future confirmatory trials with patient-centered outcomes. ClinicalTrials.gov, NCT07309393.

Figshare
Good health and well-being
Anesthesia and Sedative Agents
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon